Related Experiment Videos
Oncogenic capacity of the E2F1 gene
D G Johnson1, W D Cress, L Jakoi
1Department of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710.
Summary
The E2F1 transcription factor, especially with DP1, can promote cancer when its regulation is disrupted. This suggests E2F1
Area of Science:
- Molecular Biology
- Oncology
- Cellular Regulation
Background:
- The E2F transcription factor is a known target of cellular regulators like the Rb tumor suppressor protein.
- Alterations in cell growth control, involving E2F, are linked to human tumor development.
Purpose of the Study:
- To investigate the oncogenic potential of E2F1 and DP1 genes.
- To determine if E2F1 and DP1 can cooperate with oncogenes to drive cellular transformation.
Main Methods:
- Assayed E2F1 and DP1 gene function in cellular transformation.
- Utilized a chimeric E2F1 protein with an altered Rb-binding domain.
- Co-expressed genes with an activated ras oncogene in primary rat embryo fibroblast cultures.
- Assessed colony formation in soft agar and tumor formation in nude mice.
Main Results:
- E2F1, particularly with DP1, cooperates with activated ras to induce morphological transformation of fibroblasts.
- An E2F1-VP16 chimera showed enhanced transformation activity.
- Transfected cells formed colonies in soft agar and tumors in nude mice.
Conclusions:
- Disregulated E2F1 expression and function can lead to oncogenic consequences.
- E2F1 plays a significant role in cancer development, independent of Rb binding in some contexts.